7,696 Results

FDA approves Solana RSV + hMPV Assay as a diagnostic for infectious disease.- Quidel Corp.

 Added 1 day ago

Quidel Corporation announced that it has received clearance from the FDA to market its Solana respiratory syncytial virus (“RSV”) +...

FDA accepts sBLA for Imfinzi (durvalumab) for the treatment of patients with locally advanced (Stage III) unresectable NSCLC.- AstraZeneca.

 Added 1 day ago

AstraZeneca and MedImmune, its global biologics research and development arm,announced that the FDA has accepted a supplemental Biologics License Application...

9th Clinical Dermatology Congress

 Added 1 day ago

Breakthrough to Excellence in Clinical Dermatology, October 16–18 2017 in New York.

Impact Biomedicines to develop fedratinib to treat myelofibrosis and polycythemia vera.

 Added 2 days ago

Impact Biomedicines announced its launch to pioneer the development of life-changing treatments for patients with myeloproliferative neoplasms and other cancers. The...

Phase III CELESTIAL trial of Cabometyx (cabozantinib) meets primary endpoint in advanced hepatocellular carcinoma.- Ipsen + Exelixis.

 Added 2 days ago

Ipsen and Exelixis announced that its global phase III CELESTIAL trial met its primary endpoint of overall survival (OS), with...

Post-hoc analysis of 3 phase III trials of Plenvu demonstrate high quality cleaning in bowel cleansing.- Norgine.

 Added 2 days ago

Norgine presented new data demonstrating the superior high-quality bowel cleansing efficacy (in at least one segment of the colon) of...

FDA advisory committee recommends Rhopressa (netarsudil ophthalmic solution) 0.02%, to treat glaucoma.-Aerie Pharmaceuticals.

 Added 3 days ago

Aerie Pharmaceuticals, Inc. announced that, in their review of Aerie product candidate Rhopressa (netarsudil ophthalmic solution) 0.02%, the members of...

FDA approves Senhance System, a new robotically-assisted surgical device.- TransEnterix.

 Added 3 days ago

The FDA has cleared the Senhance System, a new robotically-assisted surgical device (RASD) that can help facilitate minimally invasive surgery.The...

9th World Congress of Melanoma

 Added 3 days ago

The 9th World Congress of Melanoma and the 14th International Congress of the Society for Melanoma Research take place this week.

CHMP recommends extension to indication for Pegasys (peg interferon alfa 2a) in hepatitis B.- Roche.

 Added 4 days ago

The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of...

Load more